TrialCardiovascular drugs and therapy2024

The SGLT2i Dapagliflozin Reduces RV Mass Independent of Changes in RV Pressure Induced by Pulmonary Artery Banding.

Kim A Connelly et al.PubMed ↗Publisher ↗

No numbers read from the abstract.